Price, David BBuhl, RolandChan, AdrianFreeman, DarylGardener, ElizabethGodley, CliffordGruffydd-Jones, KevinMcGarvey, LorcanOhta, KenRyan, DermotSyk, JörgenTan, Ngiap ChuanTan, TzeLeeThomas, MikeYang, SenKonduru, Priyanka RajuNgantcha, Marcusd'Alcontres, Martina StagnoLapperre, Therese S2018-05-032018-05-032018-01Price, D B, Buhl, R, Chan, A, Freeman, D, Gardener, E, Godley, C, Gruffydd-Jones, K, McGarvey, L, Ohta, K, Ryan, D, Syk, J, Tan, N C, Tan, T, Thomas, M, Yang, S, Konduru, P R, Ngantcha, M, d'Alcontres, M S & Lapperre, T S 2018, 'Fractional exhaled nitric oxide as a predictor of response to inhaled corticosteroids in patients with non-specific respiratory symptoms and insignificant bronchodilator reversibility : a randomised controlled trial', The Lancet. Respiratory medicine, vol. 6, no. 1, pp. 29-39. https://doi.org/10.1016/S2213-2600(17)30424-12213-2619http://hdl.handle.net/2164/10423Funding: Sponsored by OPRI with partial funding by Circassia and study drugs provided by TEVA.11330348engJournal ArticleR MedicineRFractional exhaled nitric oxide as a predictor of response to inhaled corticosteroids in patients with non-specific respiratory symptoms and insignificant bronchodilator reversibility : a randomised controlled trialJournal article10.1016/S2213-2600(17)30424-161